Corbus Pharmaceuticals Holdings, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€86.30K - Gross profit
-€86.30K - SG&A expenses
€14.34M - R&D expenses
€43.52M - EBITDA
-€49.27M - D&A
€343.49K - EBIT
-€57.86M - Interest expenses
€328.82K - EBT
-€50.02M - Tax expenses
€0.00 - Net income
-€50.02M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.20M - Changes in working capital
-€4.71M - Operating cash flow
-€49.97M - Capex
€1.73 - Other investing cash flow
€1.73 - Net investing cash flow
€25.23M - Total cash dividends paid
€0.00 - Issuance of common stock
€31.07M - Debt repayment
-€9.40M - Other financing cash flow
€0.00 - Net financing cash flow
€21.60M - Foreign exchange effects
€0.00 - Net change in cash
-€3.14M - Cash at end of period
€17.88M - Free cash flow
-€49.97M
Balance sheet
- Cash and cash equivalents
€17.30M - Cash and short-term investments
€17.30M - Total receivables
€1.29M - Inventory
€0.00 - Other current assets
€87.41M - Total current assets
€106.00M - Property, plant & equipment
€1.62M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€332.27K - Other non-current assets
€0.00 - Total non-current assets
€1.95M - Total assets
€107.95M - Accounts payable
€3.44M - Short-term debt
€2.93M - Other current liabilities
€5.14M - Total current liabilities
€11.51M - Long-term debt
€1.31M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€656.77K - Total liabilities
€12.16M - Common stock
€863.04 - Retained earnings
-€441.47M - Other equity
-€33.66K - Total equity
€95.79M - Total liabilities and shareholders' equity
€107.95M
Company information
- Market capitalization
€77.24M - Employees
28 - Enterprise Value
€93.72M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-52.2% Much better than peer group: -734.7% - ROA
-
-46.3% Much better than peer group: -441.4% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-64.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.79M